![Edward Neugeboren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Neugeboren
Directeur/Membre du Conseil chez
GRACE THERAPEUTICS, INC.
Fortune : 78 822 $ au 31/07/2026
Profil
Edward A. Neugeboren was the founder of Ledgemont Securities LLC, founded in 1999, where the title held was Managing Director from 1999 to 2013.
Mr. Neugeboren was the founder of Ledgemont Capital Group LLC, founded in 1999, holding the title of Co-Managing Director from 1999 to 2013.
Mr. Neugeboren is the founder of Quadview Healthcare Advisors LLC, founded in 2013, with the title of Managing Partner from 2013 to 2015.
Mr. Neugeboren is also the founder of Ledgemont Private Equity..
Mr. Neugeboren is currently Chief Strategy Officer at Cronus Pharma LLC since 2016.
Mr. Neugeboren is currently Independent Director at Grace Therapeutics, Inc. since 2023.
Mr. Neugeboren is currently Independent Director at Matinas BioPharma Holdings, Inc. starting 2025.
Former positions include Director at Elite Pharmaceuticals, Inc. and KineMed, Inc. Deputy Director-Equity Research at UBS Warburg, Inc. from 1995 to 1998.
Managing Director at Ridge Capital Management LLC.
Analyst at Dillon, Read & Co., Inc. from 1995 to 1997.
Analyst at Furman Selz LLC.
Chief Administrative Officer at Lehman Brothers (Market-Maker) from 1998 to 2000.
Analyst at Kidder, Peabody & Co., Inc. from 1993 to 1995.
Chief Strategy Officer at Rising Pharmaceuticals, Inc. Advisor at Healthcare Capital Corp.
(Delaware).
Principal at Arclight Advisors LLC.
Chief Strategy Officer at Casper Pharma LLC from 2016 to 2021.
Education includes an undergraduate degree from Union College (New York), conferred in 1992.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GRACE THERAPEUTICS, INC. 0,23 % | 20/07/2026 | 37 895 ( 0,23 % ) | 78 822 $ | 31/07/2026 |
Postes actifs de Edward Neugeboren
| Sociétés | Poste | Début |
|---|---|---|
| GRACE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/10/2023 |
| MATINAS BIOPHARMA HOLDINGS, INC. | Directeur/Membre du Conseil | 11/03/2025 |
Cronus Pharma LLC
 Cronus Pharma LLC Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic veterinary pharmaceutical | Corporate Officer/Principal | 01/01/2016 |
Anciens postes connus de Edward Neugeboren
| Sociétés | Poste | Fin |
|---|---|---|
| HEAE CAPI | Corporate Officer/Principal | 07/03/2022 |
Casper Pharma LLC
 Casper Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Corporate Officer/Principal | 01/12/2021 |
Ledgemont Private Equity
 Ledgemont Private Equity Investment ManagersFinance Ledgemont Private Equity focuses on a variety of sectors including technology, media and telecommunications, healthcare and pharmaceuticals and basic industrials, manufacturing and services. They generally invest $10 million to $100 million in companies with enterprise values from $50 million to $350 million. Ledgemont looks for strong management teams, companies undergoing recapitalizations or divestitures and underachieving companies due to operational or balance sheet issues | Fondateur | 24/12/2013 |
Ledgemont Securities LLC
 Ledgemont Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Fondateur | 18/03/2013 |
Formation de Edward Neugeboren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Elite Pharmaceuticals, Inc.
 Elite Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceutical products | Health Technology |
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biomarker platform technology | Commercial Services |
Grace Therapeutics, Inc.
 Grace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare and orphan diseases | Health Technology |
Ledgemont Securities LLC
Ledgemont Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Matinas BioPharma Holdings, Inc.
 Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Dillon, Read & Co., Inc.
 Dillon, Read & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Furman Selz LLC
 Furman Selz LLC Investment Banks/BrokersFinance Provides institutional brokerage and investment banking services | Finance |
Lehman Brothers (Market-Maker) | |
Union College (New York)
 Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ledgemont Capital Group LLC
 Ledgemont Capital Group LLC Investment ManagersFinance Ledgemont Capital Group seeks to make select investments in businesses across diverse industry sectors, providing equity, debt and hybrid financing with an emphasis on interim and special situation opportunities. The firm sources, structures and supports investment opportunities. They create value in our portfolio companies through concentration on business development and often gain Board representation to assist in affecting agreed strategies. Ledgemont's investment approach is grounded in through due diligence, operational expertise and the fundamental analyses of underlying businesses. Their principal investments are generally made through special purpose vehicles (SPVs). | Finance |
Ledgemont Private Equity
Ledgemont Private Equity Investment ManagersFinance Ledgemont Private Equity focuses on a variety of sectors including technology, media and telecommunications, healthcare and pharmaceuticals and basic industrials, manufacturing and services. They generally invest $10 million to $100 million in companies with enterprise values from $50 million to $350 million. Ledgemont looks for strong management teams, companies undergoing recapitalizations or divestitures and underachieving companies due to operational or balance sheet issues | Finance |
Kidder, Peabody & Co., Inc.
 Kidder, Peabody & Co., Inc. Regional BanksFinance Provides investment banking services | Finance |
UBS Warburg, Inc. | |
Rising Pharmaceuticals, Inc.
 Rising Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ridge Capital Management LLC
 Ridge Capital Management LLC Investment ManagersFinance Provides investment advice | Finance |
Arclight Advisors LLC | |
Casper Pharma LLC
Casper Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Cronus Pharma LLC
Cronus Pharma LLC Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic veterinary pharmaceutical | Health Technology |
Healthcare Capital Corp. (Delaware)
 Healthcare Capital Corp. (Delaware) Financial ConglomeratesFinance Operates as a blank check company | Finance |
